Department of Emergency and Critical Care, Veterinary Specialty Hospital of San Diego, Ethos Veterinary Health, San Diego, California, USA.
Vet Med Sci. 2024 Mar;10(2):e1374. doi: 10.1002/vms3.1374.
The objective of this article is to describe a case of suspected zonisamide-induced immune-mediated polyarthritis (IMPA) and anterior uveitis in a dog. A 7-year-old male neutered Siberian Husky with a history of refractory idiopathic epilepsy was presented for cluster seizures. Following the addition of zonisamide to the antiepileptic regime, the dog developed new IMPA and anterior uveitis. Within a few weeks of discontinuation of the zonisamide, the dog's IMPA and anterior uveitis resolved. These immune-mediated conditions were thus presumed to be an idiosyncratic reaction to zonisamide. To our knowledge, this is the first report of IMPA and anterior uveitis in dogs associated with zonisamide administration at its recommended dose.
本文旨在描述一例疑似佐米曲普坦诱导免疫介导性多关节炎(IMPA)和犬前葡萄膜炎。一只 7 岁雄性去势西伯利亚哈士奇,有难治性特发性癫痫病史,表现为簇状发作。在添加佐米曲坦到抗癫痫方案后,狗出现新的免疫介导性多关节炎和前葡萄膜炎。在停用佐米曲坦几周后,狗的免疫介导性多关节炎和前葡萄膜炎得到解决。因此,这些免疫介导性疾病被认为是佐米曲坦的特发性反应。据我们所知,这是首例在推荐剂量下使用佐米曲坦与犬免疫介导性多关节炎和前葡萄膜炎相关的报道。